Integrative Medicine for People With Parkinson’s Disease

Jennifer E. Engen

In the first installment of our new series, “Expert Voices,” Parkinson’s News Today asked neurologist Indu Subramanian, MD, to answer some of your questions related to implementing integrative medicine in Parkinson’s disease care. Dr. Subramanian is board certified in integrative medicine. She received her medical degree from the University of […]

Cognito Therapeutics Joins Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias Project to Advance Next-Generation Clinical Measures

Jennifer E. Engen

CAMBRIDGE, Mass., May 09, 2022–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, today announced it has joined the Digital Medicine Society’s (DiMe) Alzheimer’s Disease and Related Dementias (ADRD) Digital Measures Development Project to support the advancement of its late-stage disease-modifying therapeutics pipeline for neurodegenerative diseases. […]

Lower back pain termed second major disease in country

Jennifer E. Engen

KARACHI: Axial Spondyloarthritis (AXSPA) caused due to inflammation of the spinal cord, is emerging as the second major disease in Pakistan after the common cold, health experts said at an awareness seminar. AXSPA a chronic, inflammatory rheumatic disease that affects the axial skeleton, causing severe pain, stiffness and fatigue can […]

Does Crohn’s Disease Cause Hair Loss? Causes and Treatments

Jennifer E. Engen

Crohn’s disease is a form of inflammatory bowel disease (IBD). It causes chronic inflammation in the gastrointestinal (GI) tract. This inflammation can cause symptoms like pain, severe diarrhea, weight loss, and malnutrition. People with severe Crohn’s disease often experience symptoms outside their GI tract, too, like inflammation in the joints […]

Novo makes a rare disease push

Jennifer E. Engen

The pipelines of some of these therapy areas, such as lysosomal storage diseases, are crowded with gene therapy projects, but Mr Helfgott plays down Novo’s interest in such technology. “We believe gene editing is more attractive for patients than gene therapy, because it’s more durable.” To this end, Novo signed […]